Sale!

Biotech Sum of the Parts Valuation – Wall Street Prep

Original price was: $199.00.Current price is: $30.00.

-85%

We are generally active from 8 AM to 11 PM (GMT +5:30).

  • Contact us to pay with PayPal or card.
  • To check proof for this course, you can contact us via chat.
  • Instant delivery*.
Guaranteed Safe Checkout

Biotech Sum of the Parts Valuation – Wall Street Prep
Biotech Sum of the Parts Valuation – Wall Street Prep
$199.00 Original price was: $199.00.$30.00Current price is: $30.00.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Ideal for investment banking private equity and VC professionals focusing on the biotechnology industry, you will learn how to build a biotech-sum-of-the-parts valuation the way it’s done on the job.
Real World “On the Job” Biotech SOTP Valuation
Want to value a clinical-stage, pre-revenue biotech? An ordinary discounted cash flow analysis won’t cut it. Instead, you need to build a long-range sum-of-the-parts valuation.
This 60-minute video short course + model template bridges the gap between academics and the real world and equips trainees with the practical modeling skill set needed to build a biotech SOTP Valuation.
This course assumes no prior knowledge in biotech company valuation.
Excel Model Template Included: A biotech sum-of-the-parts (SOTP) model template is included with this course
What You Will Learn

Market size and model potential revenue for a therapeutic asset in clinical development
Road-map the path to commercialization for a biotech through the FDA approval process
Apply the appropriate “probability of success”” to a clinical-stage pre-revenue biotech company
Apply key assumptions and tie together a long-range forecast of multiple products with a DCF analysis

Who is This Program For?
This biotech sum-of-the-parts valuation course is designed for professionals and those pursuing a career in the following finance careers:

Investment Banking
Venture Capital
Private Equity
Anyone who wants to learn how professionals build a biotech-sum-of-the-parts valuation

Course Extras
Taught by Bankers

Our instructors are former investment bankers who give lessons real-world context by connecting it to their experience on the desk.
Used on the Street

This is the same comprehensive course our corporate clients use to prepare their analysts and associates.
Free Unlimited Access to the WSP Support Center

Receive answers to questions, free downloads, and more from our staff of experienced investment bankers.
Course TOC
Biotech Sum of the Parts Valuation

1. Biotech SOTP course welcome

2. Biotech SOTP introduction

3. Course Downloads

4. Overview of a sum of the parts valuation

5. Major building blocks for a biotech SOTP

6. Model assumptions dashboard

7. Biotech company lifecycle

8. Identify peak revenue opportunity

9. Therapeutic areas overview

10. Product launch timing and uptake curve

11. Patent life and loss of exclusivity

12. Road to commercialization

13. FDA clinical trials

14. Building a commercial infrastructure

15. Completing the SOTP

16. Probability of success

17. Build out one part of the SOTP (Product #1)

18. Finalizing the valuation model

19. Valuation sensitivities

20. Example: Blueprint Medicines Corp

21. Biotech SOTP Course Review

Reviews

There are no reviews yet.

Be the first to review “Biotech Sum of the Parts Valuation – Wall Street Prep”

Your email address will not be published. Required fields are marked *